These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6120453)

  • 41. [Sulfinpyrazone (Anturane)--new indication: myocardial infarct?].
    Bolte HD
    MMW Munch Med Wochenschr; 1980 Apr; 122(14):507-8. PubMed ID: 6769029
    [No Abstract]   [Full Text] [Related]  

  • 42. Secondary prevention of cardiac events following myocardial infarction: effects of atenolol and enalapril. Beijing Collaborative Study Group.
    Wu N; Fan Z
    Chin Med J (Engl); 1997 Aug; 110(8):602-6. PubMed ID: 9594263
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Beta-adrenoceptor blockade and myocardial infarction: when should treatment start and for how long should it continue?
    Baber NS; Lewis JA
    Circulation; 1983 Jun; 67(6 Pt 2):I71-7. PubMed ID: 6133647
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Can beta blockers be safely used in patients with recent myocardial infarction who also have congestive heart failure?
    Julian DG
    Circulation; 1983 Jun; 67(6 Pt 2):I91. PubMed ID: 6133652
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Drug treatment for secondary prevention of myocardial infarction].
    Ishikawa K; Kanamasa K; Hayashi T; Takenaka T; Inoki T; Katayama K; Miyataka M; Kimura A; Yabushita H; Taniwa T; Ikeda A
    J Cardiol; 2000 Jun; 35(6):397-408. PubMed ID: 10884976
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Sudden coronary death: what can be done to reduce it].
    da Luz PL; Murad Neto A; de Barros LF; Leite JJ; Chagas AC; Pileggi FJ
    Arq Bras Cardiol; 1980 Dec; 35(6):509-18. PubMed ID: 7259581
    [No Abstract]   [Full Text] [Related]  

  • 47. Management strategies in patients at high risk of sudden cardiac death following myocardial infarction.
    Sra J; Underwood RD; Akhtar M
    Indian Heart J; 1995; 47(2):158-62. PubMed ID: 7590846
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The role of beta-blockers in preventing sudden death in heart failure.
    Teerlink JR; Massie BM
    J Card Fail; 2000 Jun; 6(2 Suppl 1):25-33. PubMed ID: 10908095
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Letter to the neurology editor.
    Vajda FJ
    J Clin Neurosci; 2005 Feb; 12(2):210. PubMed ID: 15749437
    [No Abstract]   [Full Text] [Related]  

  • 50. [Necrotic lesions, ischemia and reperfusion: effects of beta blockers].
    Lechat P
    Arch Mal Coeur Vaiss; 1993 Jul; 86 Spec No 4():85-90. PubMed ID: 7905729
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Beta blockers for patients with lung disease?
    Harv Heart Lett; 2001 Nov; 12(3):2-3. PubMed ID: 11724686
    [No Abstract]   [Full Text] [Related]  

  • 52. [Prevention of sudden death in myocardial infarct: do experimental results help to understand the clinical reality? The case of the clinical trial SWORD (Survival With ORal D-sotalol)].
    Schwartz PJ
    Cardiologia; 1996 Aug; 41(8):739-45. PubMed ID: 8925528
    [No Abstract]   [Full Text] [Related]  

  • 53. Status of beta blocker therapy in acute myocardial infarction.
    Norris RM
    Methods Find Exp Clin Pharmacol; 1984 Apr; 6(4):219-24. PubMed ID: 6146747
    [No Abstract]   [Full Text] [Related]  

  • 54. [Secondary prevention after myocardial infarction in the aged (author's transl)].
    Michel D
    Aktuelle Gerontol; 1982 Jul; 12(4):149-54. PubMed ID: 6126140
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Critique on the use of electrophysiologic studies in the prevention of sudden death].
    Cosío Mir FG
    Rev Esp Cardiol; 1987; 40(1):25-7. PubMed ID: 3823577
    [No Abstract]   [Full Text] [Related]  

  • 56. [Beta-blockers in the therapy of myocardial infarct].
    Rossi P
    G Ital Cardiol; 1983; 13(6):462-71. PubMed ID: 6139322
    [No Abstract]   [Full Text] [Related]  

  • 57. Sudden cardiac death in patients with silent myocardial ischemia after myocardial infarction (from the Swiss Interventional Study on Silent Ischemia Type II [SWISSI II]).
    Schoenenberger AW; Kobza R; Jamshidi P; Zuber M; Abbate A; Stuck AE; Pfisterer M; Erne P
    Am J Cardiol; 2009 Jul; 104(2):158-63. PubMed ID: 19576339
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Instantaneous nonarrhythmic cardiac death in acute myocardial infarction-I.
    Zilcher H; Laimer H; Glogar D
    Am J Cardiol; 1977 Nov; 40(5):832-3. PubMed ID: 21562
    [No Abstract]   [Full Text] [Related]  

  • 59. [Can sudden death be prevented?].
    Mogensen L
    Nord Med; 1970 Sep; 84(38):1206. PubMed ID: 5469278
    [No Abstract]   [Full Text] [Related]  

  • 60. The hypokalaemia of acute myocardial infarction.
    Mikhailidis DP; Dandona P; Baron DN
    Ann Clin Biochem; 1986 Nov; 23 ( Pt 6)():700. PubMed ID: 2879506
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.